What is CVE-2022-1554?

CVE-2022-1554 is a high-severity vulnerability in Clinical-Genomics Clinical-Genomics/scout, classified under Absolute Path Traversal. CVSS score: 7.5/10. Published 2022-05-03.

How severe is CVE-2022-1554?

High severity. CVSS v3 base score is 7.5 out of 10.

Path Traversal in Clinical-Genomics Clinical-Genomics/scout

CVE-2022-1554

Path Traversal due to `send_file` call in GitHub repository clinical-genomics/scout prior to 4.52.

Published 2022-05-03 · last modified 2026-06-17.

CVSS v3 metric

CVSS v3 base score 7.5 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N.

EPSS exploit prediction

EPSS: 0.014 (70.8th percentile), scored 2026-10-01.

Low probability of exploitation in the next 30 days, but still tracked. 71st percentile — 70.8% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS over last 30 days · oldest: 0.013 · newest: 0.014 · change: +0.000

Affected products

Clinical-Genomics Clinical-Genomics/scout — versions unspecified
Clinical-Genomics Scout

Weakness classification (CWE)

References

huntr.dev/bounties/7acac778-5ba4-4f02-99e2-e4e17a81e600 (Exploit, Patch, Third Party Advisory)
github.com/clinical-genomics/scout/commit/952a2e2319af2d95d22b017a561730feac086… (Patch, Third Party Advisory)

Frequently asked questions

What is CVE-2022-1554?: CVE-2022-1554 is a high-severity vulnerability in Clinical-Genomics Clinical-Genomics/scout, classified under Absolute Path Traversal. CVSS score: 7.5/10. Published 2022-05-03.
How severe is CVE-2022-1554?: High severity. CVSS v3 base score is 7.5 out of 10.